Overview
- 16 inspections across 15 sites are on record.
- 1 Form 483 observation is attributed to this investigator.
- Most recent recorded activity is 2022-07-15.
At a glance
Inspections
16
Sites
15
Observations
1
Career since
Jun 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Revance Therapeutics, Inc. | 15 Jul 2022 | Human Drugs | On file |
| Lonza Biologics, Inc. | 6 May 2016 | Human Drugs | |
| Celltrion Branchburg, LLC | 24 Mar 2016 | Human Drugs | |
| Lotte Biologics USA, LLC | 9 Oct 2015 | Human Drugs | |
| United Therapeutics Corporation | 13 Jun 2014 | Human Drugs | On file |
Sites inspected
Revance Therapeutics, Inc.Newark, United States1 insp.
Lonza Biologics, Inc.Portsmouth, United States1 insp.
Celltrion Branchburg, LLCBranchburg, United States1 insp.
Lotte Biologics USA, LLCEast Syracuse, United States1 insp.
United Therapeutics CorporationSilver Spring, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sarah A Johnson1 shared
Virginia A Carroll1 shared
Donald C Obenhuber1 shared
Anastasia G Lolas1 shared
Mary E Farbman1 shared
Full investigator report
Get the verbatim findings behind Patricia F Hughes Troost's 1 observation
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site